The purpose of this study is to compare the usual treatment of SRS to FSRS. Learn more about the NRG-BN013 trial or call the Reading Hospital Cancer Research Office at 484-628-8193.
NRG-BN013
Phase III Trial of Single Fraction Stereotactic Radiosurgery (SRS) Versus Fractionated SRS (FSRS) for Intact Brain Metastases
